Page last updated: 2024-11-08

biochanin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5280373
CHEMBL ID131921
CHEBI ID17574
SCHEMBL ID61258
MeSH IDM0045640

Synonyms (131)

Synonym
BIDD:ER0123
MLS001148446
AKOS002163860
BRD-K73303757-001-02-6
gtpl2829
5,7-dihydroxy-4'-methoxyisoflavone
4'-methylgenistein
4h-1-benzopyran-4-one,7-dihydroxy-3-(4-methoxyphenyl)-
genistein 4-methyl ether
nsc123538 ,
biochanin
nsc-123538
biochanin-a ,
biochanine a
isoflavone,7-dihydroxy-4'-methoxy-
5,7-dihydroxy-3-(4-methoxyphenyl)-4h-1-benzopyran-4-one
5,7-dihydroxy-3-p-methoxyphenyl-4h-chromen-4-one
CHEBI:17574 ,
pratensol
5,7-dihydroxy-3-(4-methoxyphenyl)-4h-chromen-4-one
MLS000069443 ,
DIVK1C_001027
KBIO1_001027
nsc 123538
ccris 5449
isoflavone, 5,7-dihydroxy-4'-methoxy-
einecs 207-744-7
SPECTRUM_000195
SPECTRUM4_001927
BSPBIO_002776
NCGC00017369-01
tnp00319
IDI1_001027
NCGC00178478-01
4h-1-benzopyran-4-one, 5,7-dihydroxy-3-(4-methoxyphenyl)-
5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one
OPREA1_038096
SMP1_000045
C00814
491-80-5
biochanin a ,
bdbm9461
cid_5280373
biochanin a, 9
chembl131921 ,
biochanin a (bca)
SPECTRUM5_001624
NCGC00022428-05
NCGC00022428-03
smr000059116
KBIOSS_000675
KBIO3_001996
NCI60_000558
KBIO2_003243
KBIO2_005811
KBIO2_000675
KBIOGR_002274
SPECTRUM3_001098
SPECTRUM2_000047
NINDS_001027
SPBIO_000173
SPECTRUM10100003
NCGC00017369-02
NCGC00022428-04
5,7-dihydroxy-4'-methoxy-isoflavone
2AA2D226-B323-4AE2-B576-2D47D15F9845
HMS503M15
FT-0663120
STK888295
LMPK12050229
5,7-dihydrox -4'-methoxyisoflavone
unii-u13j6u390t
u13j6u390t ,
tox21_302901
cas-491-80-5
dtxcid102394
NCGC00256458-01
dtxsid1022394 ,
tox21_202097
NCGC00259646-01
BBL010523
BIOCHANIN A - 4-METHYLGENISTEIN
HMS2232N19
CCG-38351
NCGC00017369-06
NCGC00017369-08
NCGC00017369-04
NCGC00017369-03
NCGC00017369-07
NCGC00017369-09
NCGC00017369-05
4-methylgenistein
qso ,
F1190-0491
NCGC00017369-10
biochanin a [usp-rs]
biochanin a (constituent of red clover) [dsc]
biochanin a [mi]
S2377
HMS3369A02
HY-14595
SCHEMBL61258
genistein 4'-methyl ether
B4098
olmelin
MLS006011785
Q-100552
5,7-dihydroxy-3-(4-methoxyphenyl)-4h-chromen-4-one #
4'-methoxy-5,7-dihydroxy isoflavone
OPERA_ID_621
mfcd00006839
AC-22309
biochanin a, united states pharmacopeia (usp) reference standard
HMS3656A13
5,7-dihydroxy-4'-methoxy-isoflavone (8ci)
biochanin a, analytical reference material
biochanina
SR-01000003021-4
SR-01000003021-5
sr-01000003021
SW219333-1
biochanin a (bio)
biochanin a (4-methylgenistein)
DB15334
AS-17474
Q864222
BRD-K73303757-001-12-5
biochanin a (constituent of red clover)
genistein 4-methylether
biochanin a (usp-rs)
SY048226

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" These results indicate that isoflavones can be considered safe compounds."( Red clover and soy isoflavones--an in vitro safety assessment.
Gerster, P; Jungbauer, A; Reiter, E, 2011
)
0.37
" Among various adverse effects of PIs, hepatotoxicity is a very common adverse reaction of RIT which is concentration dependent."( Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules.
Agarwal, NK; Azmi, L; Chaturvedi, S; Malik, MY; Naseem, Z; Rao, C; Shukla, I, 2018
)
0.48
"Five groups of animals were subjected to treatment as control, toxic control (RIT), third group (RIT + FMN), fourth group (RIT + BCA), the fifth group (RIT + FMN + BCA) and sixth group (FMN + BCA) for 14 days."( Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules.
Agarwal, NK; Azmi, L; Chaturvedi, S; Malik, MY; Naseem, Z; Rao, C; Shukla, I, 2018
)
0.48

Pharmacokinetics

ExcerptReferenceRelevance
"Isoflavones have pharmacokinetic characteristics that suggest that once-daily administration is adequate when they are administered long-term as dietary supplements."( Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense).
Howes, J; Howes, LG; Huang, L; Waring, M, 2002
)
0.31
" No significant changes in mean residence time and terminal half-life were observed for all drugs, suggesting a negligible effect of BA on their hepatic/renal elimination."( Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A.
Cousineau, M; Danser, E; Dewire, R; Floden, J; Peng, SX; Ritchie, DM, 2006
)
0.33
" The pharmacokinetic parameters of BCA were analyzed by noncompartmental analysis."( Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.
Frederick, K; Moon, YJ; Morris, ME; Sagawa, K; Zhang, S, 2006
)
0.33
"Little is known regarding pharmacokinetic (PK) or pharmacodynamic interactions of flavonoids with each other: this is of significance since multiple flavonoids are present in the diet and in dietary supplements."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.13
" A reliable sensitive reversed-phase high-performance liquid chromatography (RP-HPLC) method with UV detection for the pharmacokinetic study of taxifolin in rabbit plasma after enzymatic hydrolysis was developed and validated for the first time."( Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.
Karlina, MV; Kosman, VM; Makarov, VG; Makarova, MN; Pozharitskaya, ON; Shikov, AN, 2009
)
0.35

Bioavailability

The present study aimed to improve the bioavailability of biochanin A, a poorly soluble bioflavonoid, via the preparation of solid dispersion (SD) using Solutol HS15 and HPMC 2910. The disconnect between the in vitro and in vivo data suggests that P-gp interactions mediated by biochanIn A may be limited due to its poor bioavailability and rapid clearance.

ExcerptReferenceRelevance
" MRP type efflux pumps may limit the bioavailability of EGCG."( Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites.
Hong, J; Lambert, JD; Lee, SH; Sinko, PJ; Yang, CS, 2003
)
0.32
" Both BCA and GEN were found to have a high clearance and a large apparent volume of distribution; the bioavailability of both was poor (<4%)."( Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.
Frederick, K; Moon, YJ; Morris, ME; Sagawa, K; Zhang, S, 2006
)
0.33
" Our objective was to determine the effect of quercetin and (-)-epigallocatechin-3-gallate (EGCG), major flavonoids present in the diet, on the PK and bioavailability of biochanin A, a flavonoid with chemopreventive properties."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.13
" The absolute bioavailability of taxifolin after oral administration of lipid solution was 36%."( Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography.
Karlina, MV; Kosman, VM; Makarov, VG; Makarova, MN; Pozharitskaya, ON; Shikov, AN, 2009
)
0.35
" The disconnect between the in vitro and in vivo data suggests that P-gp interactions mediated by biochanin A may be limited due to its poor bioavailability and rapid clearance."( Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo.
Arnold, RD; Morris, ME; Sagawa, K; Tseng, E; Wang, X; Zhang, S, 2010
)
0.36
"The present study aimed to improve the bioavailability of biochanin A, a poorly soluble bioflavonoid, via the preparation of solid dispersion (SD) using Solutol HS15 and HPMC 2910."( Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: in vitro and in vivo evaluation.
Han, HK; Lee, BJ; Lee, HK, 2011
)
0.37
" As BCA is an inhibitor of CYP 3A and P-gp it was expected to increase the bioavailability of tamoxifen, a known substrate of CYP3A4/Pgp."( Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
Ali, MM; Jain, GK; Kohli, K; Raju, KS; Singh, SP, 2012
)
0.38
" Ingested BCA is known to display low bioavailability due to poor solubility, extensive metabolism and rapid clearance."( Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
Alexi, X; Alexis, MN; Aligiannis, N; Fokialakis, N; Meligova, AK; Mitakou, S; Pratsinis, H; Siriani, D, 2012
)
0.38
" This study suggested that PEG-NLC is a novel anti-cancer nanoparticle, which could provide attractive treatment for a wide variety of tumors and improved the oral bioavailability of poorly water-soluble drug."( PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
Chen, W; Ji, Z; Jia, B; Li, R; Lin, T; Luo, Q; Song, J; Wang, L; Zhang, C; Zhou, K; Zhu, G; Zhu, T, 2015
)
0.42
", and the in vitro dissolution results support the use of a buccal formulation to potentially improve its bioavailability in antichlamydial or other pharmaceutical applications."( Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.
Elofsson, M; Genina, N; Gylfe, Å; Hanski, L; Hirvonen, J; Kolakovic, R; Laaksonen, T; Mäkilä, E; Malinovskaja, K; Salonen, J; Sandler, N; Uvell, H; Vuorela, PM, 2014
)
0.4
" Bioavailability and metabolism of these red clover isoflavones (RCI) have not been studied in detail."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
"To determine the bioavailability of RCI metabolites and analyse whether FOS supplementation could influence their bioavailability."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
" In the first, compound bioavailability was determined after consumption of 80 mg of RCI (MF11RCE)."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
" Supplementation with FOS led to a significant decrease in the bioavailability of daidzein, dihydroformononetin, dihydrogenistein and dihydrodaidzein."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
"This study is the first to provide detailed data on RCI bioavailability in humans and determine no influence of FOS yet a trend toward increased equol production."( Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.
Chedraui, P; Hobiger, S; Imhof, M; Jungbauer, A; Laschitz, T; Lipovac, M; Pfitscher, A, 2015
)
0.42
"Enteric coating of microparticles prevents stomach degradation and enhances oral bioavailability of poorly soluble drugs."( Development and characterization of enteric-coated microparticles of biochanin A for their beneficial pharmacological potential in estrogen deficient-hypertension.
Mishra, N; Sachdeva, C; Sharma, S, 2016
)
0.43
"16-fold increase in the relative oral bioavailability of BCA-FS compared with raw BCA, indicating that the mixed micelles may promote absorption in the gastrointestinal tract."( Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630.
Cui, L; Ge, W; Hou, J; Shao, T; Wang, J; Wu, W; Wu, X; Zhang, Z, 2017
)
0.46
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

biochanin A, flavone, or chrysin could inhibit the activity of estradiol in a dose-response manner with IC50 values of 500 nM, 2 microM, and 10 microM. Real time PCR and SDS-PAGE were applied to detect the expression of MRSA41577 norA.

ExcerptRelevanceReference
" However, biochanin A, flavone, or chrysin could inhibit the activity of estradiol in a dose-response manner with IC50 values of 500 nM, 2 microM, and 10 microM, respectively."( The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast.
Arnold, SF; Collins, BM; McLachlan, JA, 1997
)
0.3
"Trough plasma levels were significantly higher for daidzein and genistein after long-term dosing than levels taken prior to the commencement of the study and plasma levels of isoflavones after long-term dosing were in the range previously reported in populations that consume an isoflavone-rich diet."( Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense).
Howes, J; Howes, LG; Huang, L; Waring, M, 2002
)
0.31
" At a dosage of 250 microg/pellet the red clover extract showed excellent inhibition of angiogenesis."( Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.).
Krenn, L; Paper, DH, 2009
)
0.35
" Dose-response action for the different isoflavonoids showed that BCA is highly effective on glioma cells and nontoxic for normal differentiated brain tissues."( The impact of dietary isoflavonoids on malignant brain tumors.
Buchfelder, M; Doerfler, A; Engelhorn, T; Eyüpoglu, IY; Fan, Z; Hore, N; Savaskan, NE; Schwarz, M; Sehm, T; Weiss, R, 2014
)
0.4
" Real time PCR and SDS-PAGE were applied to detect the expression of MRSA41577 norA and to analyze the changes of MRSA41577 efflux protein before and after dosing biochanin A in association with liquid chromatography mass spectrometry to determinate protein variation."( [Inhibitory effects of biochanin A on the efflux pump of methicillin-resistant Staphylococcus aureus (MRSA)].
Chen, Y; Wang, H; Xie, K; Xie, M; Zou, D, 2014
)
0.4
" After development and validation of DOX resistant cells of COLO205 (ColoR), dosing ratio of DOX and BioA for reversal of DOX resistance was determined by co-treatment in ColoR cells."( Formulation and Optimization of Doxorubicin and Biochanin A Combinational Liposomes for Reversal of Chemoresistance.
Dash, TK; Konkimalla, VB, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
phytoestrogenAny compound produced by a plant that happens to have estrogenic activity.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitorAn EC 3.5.1.* (non-peptide linear amide C-N hydrolase) inhibitor that interferes with the action of fatty acid amide hydrolase (EC 3.5.1.99).
tyrosine kinase inhibitorAny protein kinase inhibitor that interferes with the action of tyrosine kinase.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
7-hydroxyisoflavonesA hydroxyisoflavone compound having a hydroxy group at the 7-position.
4'-methoxyisoflavonesAny methoxyisoflavone which has a methoxy group at the 4-position of the phenyl substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (117)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency39.81070.003245.467312,589.2998AID2517
Chain A, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency33.55210.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency1.25890.125919.1169125.8920AID2549
Chain A, Ferritin light chainEquus caballus (horse)Potency31.62285.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency5.80490.007215.758889.3584AID1224835; AID588342
glp-1 receptor, partialHomo sapiens (human)Potency0.50120.01846.806014.1254AID624417
BRCA1Homo sapiens (human)Potency2.51190.89137.722525.1189AID624202
phosphopantetheinyl transferaseBacillus subtilisPotency50.11870.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency52.82583.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.33390.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency22.05180.173734.304761.8120AID1346859
ATAD5 protein, partialHomo sapiens (human)Potency10.79590.004110.890331.5287AID504466; AID504467; AID686934; AID720565
PPM1D proteinHomo sapiens (human)Potency16.53880.00529.466132.9993AID1347411
SMAD family member 3Homo sapiens (human)Potency22.05180.173734.304761.8120AID1346859
TDP1 proteinHomo sapiens (human)Potency25.69230.000811.382244.6684AID686978; AID686979
GLI family zinc finger 3Homo sapiens (human)Potency10.38280.000714.592883.7951AID1259368; AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency15.35520.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency14.49120.000221.22318,912.5098AID1259243; AID1259247; AID1259381; AID743035; AID743040; AID743042; AID743053; AID743054; AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency7.07950.011212.4002100.0000AID1030
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Homo sapiens (human)Potency10.00000.00137.762544.6684AID914; AID915
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency7.66010.000657.913322,387.1992AID1259377; AID1259378; AID1259394
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency23.77940.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency6.13790.000417.946075.1148AID1346795
EWS/FLI fusion proteinHomo sapiens (human)Potency37.22120.001310.157742.8575AID1259252
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.94770.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.61890.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency38.20910.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency6.58470.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency15.48640.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency30.76260.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.30500.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743075; AID743077; AID743078; AID743079; AID743080; AID743091
glucocerebrosidaseHomo sapiens (human)Potency2.23870.01268.156944.6684AID2101
P53Homo sapiens (human)Potency56.23410.07319.685831.6228AID504706
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency21.63240.001024.504861.6448AID743212; AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency28.81960.001019.414170.9645AID743094; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency7.76160.023723.228263.5986AID743222
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency12.58930.016525.307841.3999AID602332
aryl hydrocarbon receptorHomo sapiens (human)Potency8.32040.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.34520.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency57.60120.143427.612159.8106AID1159516; AID1159519
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency38.499819.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency66.59520.057821.109761.2679AID1159526
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency31.62280.00207.533739.8107AID891
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.23870.01262.451825.0177AID485313
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency11.29470.316212.443531.6228AID902; AID924
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency15.84891.000012.232631.6228AID1452
cytochrome P450 2C19 precursorHomo sapiens (human)Potency7.94330.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency0.02510.00636.904339.8107AID883
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency35.48130.001815.663839.8107AID894
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency15.84893.548119.542744.6684AID743266
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency63.25940.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency16.64440.037617.082361.1927AID1259364; AID1259388
mitogen-activated protein kinase 1Homo sapiens (human)Potency15.84890.039816.784239.8107AID995
ras-related protein Rab-9AHomo sapiens (human)Potency2.81840.00022.621531.4954AID485297
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency30.08300.000627.21521,122.0200AID743202; AID743219
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency2.23870.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency2.23870.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency2.23870.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency24.03530.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency9.81220.004611.374133.4983AID624296
survival motor neuron protein isoform dHomo sapiens (human)Potency18.86770.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency19.95260.031610.279239.8107AID884; AID885
lamin isoform A-delta10Homo sapiens (human)Potency28.18380.891312.067628.1838AID1487
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency1.64000.001557.789015,848.9004AID1259244
Interferon betaHomo sapiens (human)Potency16.53880.00339.158239.8107AID1347411
Cellular tumor antigen p53Homo sapiens (human)Potency60.44560.002319.595674.0614AID651631; AID720552
Integrin beta-3Homo sapiens (human)Potency12.58930.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency12.58930.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency1.64000.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency0.02510.00638.235039.8107AID883
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
TAR DNA-binding protein 43Homo sapiens (human)Potency3.16231.778316.208135.4813AID652104
GABA theta subunitRattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency3.00150.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency2.61840.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency19.95261.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki0.05250.00021.10439.9000AID1254159
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)36.10000.00101.94459.6000AID1265116
Lysine-specific histone demethylase 1AHomo sapiens (human)IC50 (µMol)2.95000.00312.16029.6000AID1845956; AID1854423; AID1872429
Pancreatic triacylglycerol lipaseSus scrofa (pig)IC50 (µMol)100.00000.00401.10246.5000AID1242901
Carbonic anhydrase 1Homo sapiens (human)Ki10.00000.00001.372610.0000AID1254155
Carbonic anhydrase 2Homo sapiens (human)Ki10.00000.00000.72369.9200AID1254156
Triosephosphate isomeraseOryctolagus cuniculus (rabbit)Ki12.00001.41002.00502.6000AID238451
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)IC50 (µMol)100.00000.07002.12673.5000AID1802929
Androgen receptorHomo sapiens (human)IC50 (µMol)1,600.00000.00000.875310.0000AID429119
AromataseHomo sapiens (human)IC50 (µMol)5,647,399,985.00170.00001.290410.0000AID1250230; AID241414; AID242139; AID243423; AID479369; AID654681
AromataseHomo sapiens (human)Ki12.00000.00000.60469.5010AID1796327; AID1796373; AID238451; AID244080
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)127.00000.00101.191310.0000AID1265119
Carbonyl reductase [NADPH] 1Homo sapiens (human)IC50 (µMol)12.71000.40002.03003.7800AID347259
Carbonyl reductase [NADPH] 1Homo sapiens (human)Ki2.03000.06001.12503.4300AID347259
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)0.40000.00002.37899.7700AID125222
Carbonic anhydrase 4Homo sapiens (human)Ki7.07850.00021.97209.9200AID1254157
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)0.40000.00001.89149.5700AID125222
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)IC50 (µMol)10.80000.00261.76469.3000AID1799665
17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)IC50 (µMol)9.90000.09603.94009.9000AID1364654; AID406997
Carbonic anhydrase 7Homo sapiens (human)Ki0.37150.00021.37379.9000AID1254158
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)8.00000.03002.94428.0000AID265758
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)EC50 (µMol)55.94100.05905.559627.2100AID1241
signal transducer and activator of transcription 1-alpha/beta isoform alphaHomo sapiens (human)EC50 (µMol)2.06000.41801.36182.9980AID1397
transcription factor p65 isoform 1Homo sapiens (human)EC50 (µMol)55.94100.05905.559627.2100AID1241
Estrogen receptor betaMus musculus (house mouse)EC50 (µMol)55.94100.05905.559627.2100AID1241
Estrogen receptorMus musculus (house mouse)EC50 (µMol)55.94100.05905.559627.2100AID1241
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Glucocorticoid receptorHomo sapiens (human)EC150 (µMol)4.20000.00053.62157.1000AID429117
Androgen receptorHomo sapiens (human)EC150 (µMol)4.20000.00053.58477.1000AID429115
AromataseHomo sapiens (human)Log IC500.00450.00340.00400.0045AID243262
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (415)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
regulation of double-strand break repair via homologous recombinationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of protein ubiquitinationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of protein localizationLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to UVLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to gamma radiationLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair-dependent chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuroblast proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
protein demethylationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of epithelial to mesenchymal transitionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neuron projection developmentLysine-specific histone demethylase 1AHomo sapiens (human)
cerebral cortex developmentLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
neuron maturationLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cell sizeLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of DNA-templated transcriptionLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of transcription by RNA polymerase IILysine-specific histone demethylase 1AHomo sapiens (human)
guanine metabolic processLysine-specific histone demethylase 1AHomo sapiens (human)
muscle cell developmentLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of androgen receptor signaling pathwayLysine-specific histone demethylase 1AHomo sapiens (human)
response to fungicideLysine-specific histone demethylase 1AHomo sapiens (human)
cellular response to cAMPLysine-specific histone demethylase 1AHomo sapiens (human)
regulation of DNA methylation-dependent heterochromatin formationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of cold-induced thermogenesisLysine-specific histone demethylase 1AHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of neural precursor cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
positive regulation of stem cell proliferationLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin remodelingLysine-specific histone demethylase 1AHomo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
regulation of gluconeogenesisGlucocorticoid receptorHomo sapiens (human)
chromatin organizationGlucocorticoid receptorHomo sapiens (human)
regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
apoptotic processGlucocorticoid receptorHomo sapiens (human)
chromosome segregationGlucocorticoid receptorHomo sapiens (human)
signal transductionGlucocorticoid receptorHomo sapiens (human)
glucocorticoid metabolic processGlucocorticoid receptorHomo sapiens (human)
gene expressionGlucocorticoid receptorHomo sapiens (human)
microglia differentiationGlucocorticoid receptorHomo sapiens (human)
adrenal gland developmentGlucocorticoid receptorHomo sapiens (human)
regulation of glucocorticoid biosynthetic processGlucocorticoid receptorHomo sapiens (human)
synaptic transmission, glutamatergicGlucocorticoid receptorHomo sapiens (human)
maternal behaviorGlucocorticoid receptorHomo sapiens (human)
intracellular glucocorticoid receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
glucocorticoid mediated signaling pathwayGlucocorticoid receptorHomo sapiens (human)
positive regulation of neuron apoptotic processGlucocorticoid receptorHomo sapiens (human)
negative regulation of DNA-templated transcriptionGlucocorticoid receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
astrocyte differentiationGlucocorticoid receptorHomo sapiens (human)
cell divisionGlucocorticoid receptorHomo sapiens (human)
mammary gland duct morphogenesisGlucocorticoid receptorHomo sapiens (human)
motor behaviorGlucocorticoid receptorHomo sapiens (human)
cellular response to steroid hormone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to glucocorticoid stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to dexamethasone stimulusGlucocorticoid receptorHomo sapiens (human)
cellular response to transforming growth factor beta stimulusGlucocorticoid receptorHomo sapiens (human)
neuroinflammatory responseGlucocorticoid receptorHomo sapiens (human)
positive regulation of miRNA transcriptionGlucocorticoid receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayGlucocorticoid receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIGlucocorticoid receptorHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
MAPK cascadeAndrogen receptorHomo sapiens (human)
in utero embryonic developmentAndrogen receptorHomo sapiens (human)
regulation of systemic arterial blood pressureAndrogen receptorHomo sapiens (human)
epithelial cell morphogenesisAndrogen receptorHomo sapiens (human)
transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
signal transductionAndrogen receptorHomo sapiens (human)
G protein-coupled receptor signaling pathwayAndrogen receptorHomo sapiens (human)
cell-cell signalingAndrogen receptorHomo sapiens (human)
spermatogenesisAndrogen receptorHomo sapiens (human)
single fertilizationAndrogen receptorHomo sapiens (human)
positive regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
negative regulation of cell population proliferationAndrogen receptorHomo sapiens (human)
positive regulation of gene expressionAndrogen receptorHomo sapiens (human)
male somatic sex determinationAndrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
intracellular receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
Leydig cell differentiationAndrogen receptorHomo sapiens (human)
multicellular organism growthAndrogen receptorHomo sapiens (human)
positive regulation of phosphorylationAndrogen receptorHomo sapiens (human)
positive regulation of MAPK cascadeAndrogen receptorHomo sapiens (human)
positive regulation of insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
positive regulation of cell differentiationAndrogen receptorHomo sapiens (human)
negative regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of integrin biosynthetic processAndrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAndrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIIAndrogen receptorHomo sapiens (human)
insulin-like growth factor receptor signaling pathwayAndrogen receptorHomo sapiens (human)
regulation of developmental growthAndrogen receptorHomo sapiens (human)
animal organ formationAndrogen receptorHomo sapiens (human)
male genitalia morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell proliferationAndrogen receptorHomo sapiens (human)
negative regulation of epithelial cell proliferationAndrogen receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityAndrogen receptorHomo sapiens (human)
activation of prostate induction by androgen receptor signaling pathwayAndrogen receptorHomo sapiens (human)
morphogenesis of an epithelial foldAndrogen receptorHomo sapiens (human)
lateral sprouting involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
prostate gland growthAndrogen receptorHomo sapiens (human)
prostate gland epithelium morphogenesisAndrogen receptorHomo sapiens (human)
epithelial cell differentiation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
tertiary branching involved in mammary gland duct morphogenesisAndrogen receptorHomo sapiens (human)
mammary gland alveolus developmentAndrogen receptorHomo sapiens (human)
positive regulation of epithelial cell proliferation involved in prostate gland developmentAndrogen receptorHomo sapiens (human)
cellular response to steroid hormone stimulusAndrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusAndrogen receptorHomo sapiens (human)
cellular response to testosterone stimulusAndrogen receptorHomo sapiens (human)
seminiferous tubule developmentAndrogen receptorHomo sapiens (human)
non-membrane-bounded organelle assemblyAndrogen receptorHomo sapiens (human)
positive regulation of miRNA transcriptionAndrogen receptorHomo sapiens (human)
regulation of protein localization to plasma membraneAndrogen receptorHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathwayAndrogen receptorHomo sapiens (human)
male gonad developmentAndrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayAndrogen receptorHomo sapiens (human)
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
xenobiotic metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
glucocorticoid metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
cyclooxygenase pathwayCarbonyl reductase [NADPH] 1Homo sapiens (human)
epithelial cell differentiationCarbonyl reductase [NADPH] 1Homo sapiens (human)
vitamin K metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCarbonyl reductase [NADPH] 1Homo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
bicarbonate transportCarbonic anhydrase 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 4Homo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
androgen biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
male genitalia developmentTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
steroid biosynthetic processTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
in utero embryonic development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
placenta development17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
estrogen biosynthetic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
androgen metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
response to retinoic acid17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
steroid metabolic process17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 7Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 7Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 7Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 7Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 7Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 7Homo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (137)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
telomeric DNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
p53 bindingLysine-specific histone demethylase 1AHomo sapiens (human)
chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
oxidoreductase activityLysine-specific histone demethylase 1AHomo sapiens (human)
enzyme bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear receptor coactivator activityLysine-specific histone demethylase 1AHomo sapiens (human)
demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K4 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
histone H3K9 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
identical protein bindingLysine-specific histone demethylase 1AHomo sapiens (human)
MRF bindingLysine-specific histone demethylase 1AHomo sapiens (human)
flavin adenine dinucleotide bindingLysine-specific histone demethylase 1AHomo sapiens (human)
nuclear androgen receptor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
telomeric repeat-containing RNA bindingLysine-specific histone demethylase 1AHomo sapiens (human)
DNA-binding transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
FAD-dependent H3K4me/H3K4me3 demethylase activityLysine-specific histone demethylase 1AHomo sapiens (human)
promoter-specific chromatin bindingLysine-specific histone demethylase 1AHomo sapiens (human)
transcription factor bindingLysine-specific histone demethylase 1AHomo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
core promoter sequence-specific DNA bindingGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificGlucocorticoid receptorHomo sapiens (human)
DNA-binding transcription factor activityGlucocorticoid receptorHomo sapiens (human)
RNA bindingGlucocorticoid receptorHomo sapiens (human)
nuclear receptor activityGlucocorticoid receptorHomo sapiens (human)
nuclear glucocorticoid receptor activityGlucocorticoid receptorHomo sapiens (human)
steroid bindingGlucocorticoid receptorHomo sapiens (human)
protein bindingGlucocorticoid receptorHomo sapiens (human)
zinc ion bindingGlucocorticoid receptorHomo sapiens (human)
TBP-class protein bindingGlucocorticoid receptorHomo sapiens (human)
protein kinase bindingGlucocorticoid receptorHomo sapiens (human)
identical protein bindingGlucocorticoid receptorHomo sapiens (human)
Hsp90 protein bindingGlucocorticoid receptorHomo sapiens (human)
steroid hormone bindingGlucocorticoid receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingGlucocorticoid receptorHomo sapiens (human)
estrogen response element bindingGlucocorticoid receptorHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
transcription cis-regulatory region bindingAndrogen receptorHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
RNA polymerase II general transcription initiation factor bindingAndrogen receptorHomo sapiens (human)
transcription coactivator bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificAndrogen receptorHomo sapiens (human)
chromatin bindingAndrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityAndrogen receptorHomo sapiens (human)
nuclear receptor activityAndrogen receptorHomo sapiens (human)
G protein-coupled receptor activityAndrogen receptorHomo sapiens (human)
signaling receptor bindingAndrogen receptorHomo sapiens (human)
steroid bindingAndrogen receptorHomo sapiens (human)
androgen bindingAndrogen receptorHomo sapiens (human)
protein bindingAndrogen receptorHomo sapiens (human)
beta-catenin bindingAndrogen receptorHomo sapiens (human)
zinc ion bindingAndrogen receptorHomo sapiens (human)
enzyme bindingAndrogen receptorHomo sapiens (human)
ATPase bindingAndrogen receptorHomo sapiens (human)
molecular adaptor activityAndrogen receptorHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingAndrogen receptorHomo sapiens (human)
POU domain bindingAndrogen receptorHomo sapiens (human)
molecular condensate scaffold activityAndrogen receptorHomo sapiens (human)
estrogen response element bindingAndrogen receptorHomo sapiens (human)
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
carbonyl reductase (NADPH) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptorCarbonyl reductase [NADPH] 1Homo sapiens (human)
oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptorCarbonyl reductase [NADPH] 1Homo sapiens (human)
15-hydroxyprostaglandin-D dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NADP+) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
prostaglandin-E2 9-reductase activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
S-nitrosoglutathione reductase (NADPH) activityCarbonyl reductase [NADPH] 1Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingCarbonic anhydrase 4Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 4Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 4Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone dehydrogenase [NAD(P)] activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
17-beta-hydroxysteroid dehydrogenase (NADP+) activityTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
testosterone dehydrogenase (NAD+) activity17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 7Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 7Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (78)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
chromatinLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
chromosome, telomeric regionLysine-specific histone demethylase 1AHomo sapiens (human)
nucleusLysine-specific histone demethylase 1AHomo sapiens (human)
nucleoplasmLysine-specific histone demethylase 1AHomo sapiens (human)
transcription regulator complexLysine-specific histone demethylase 1AHomo sapiens (human)
protein-containing complexLysine-specific histone demethylase 1AHomo sapiens (human)
DNA repair complexLysine-specific histone demethylase 1AHomo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleusGlucocorticoid receptorHomo sapiens (human)
nucleoplasmGlucocorticoid receptorHomo sapiens (human)
cytoplasmGlucocorticoid receptorHomo sapiens (human)
mitochondrial matrixGlucocorticoid receptorHomo sapiens (human)
centrosomeGlucocorticoid receptorHomo sapiens (human)
spindleGlucocorticoid receptorHomo sapiens (human)
cytosolGlucocorticoid receptorHomo sapiens (human)
membraneGlucocorticoid receptorHomo sapiens (human)
nuclear speckGlucocorticoid receptorHomo sapiens (human)
synapseGlucocorticoid receptorHomo sapiens (human)
chromatinGlucocorticoid receptorHomo sapiens (human)
protein-containing complexGlucocorticoid receptorHomo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
plasma membraneAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
nucleoplasmAndrogen receptorHomo sapiens (human)
cytoplasmAndrogen receptorHomo sapiens (human)
cytosolAndrogen receptorHomo sapiens (human)
nuclear speckAndrogen receptorHomo sapiens (human)
chromatinAndrogen receptorHomo sapiens (human)
protein-containing complexAndrogen receptorHomo sapiens (human)
nucleusAndrogen receptorHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolCarbonyl reductase [NADPH] 1Homo sapiens (human)
extracellular exosomeCarbonyl reductase [NADPH] 1Homo sapiens (human)
extracellular vesicleCarbonyl reductase [NADPH] 1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 4Homo sapiens (human)
rough endoplasmic reticulumCarbonic anhydrase 4Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentCarbonic anhydrase 4Homo sapiens (human)
Golgi apparatusCarbonic anhydrase 4Homo sapiens (human)
trans-Golgi networkCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
external side of plasma membraneCarbonic anhydrase 4Homo sapiens (human)
cell surfaceCarbonic anhydrase 4Homo sapiens (human)
membraneCarbonic anhydrase 4Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 4Homo sapiens (human)
transport vesicle membraneCarbonic anhydrase 4Homo sapiens (human)
secretory granule membraneCarbonic anhydrase 4Homo sapiens (human)
brush border membraneCarbonic anhydrase 4Homo sapiens (human)
perinuclear region of cytoplasmCarbonic anhydrase 4Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 4Homo sapiens (human)
plasma membraneCarbonic anhydrase 4Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulum membraneTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
intracellular membrane-bounded organelleTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulumTestosterone 17-beta-dehydrogenase 3Homo sapiens (human)
endoplasmic reticulum membrane17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
intracellular membrane-bounded organelle17-beta-hydroxysteroid dehydrogenase type 2Homo sapiens (human)
cytosolCarbonic anhydrase 7Homo sapiens (human)
cytoplasmCarbonic anhydrase 7Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (395)

Assay IDTitleYearJournalArticle
AID334637Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction
AID1083070Phytotoxicity against Silene noctiflora assessed as root growth inhibition after 2 weeks by agar medium bioassay2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID658969Growth stimulation of estrogen-deficient human MCF7 cells at 0.01 to 10 uM after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID347254Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1502920Cytotoxicity in human monocyte-derived macrophages assessed as reduction in cell viability incubated for 3 days by alamar blue dye based assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1386838Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of basal PRE activity at 50 uM after 24 hrs in absence of progesterone by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1887458Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 20 uM incubated for 24 hr by wound healing assay (Rvb = 1.757 +/- 0.094 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID84191Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1386839Agonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as increase in progesterone-induced PRE activity at 1 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID406997Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1254155Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID469802Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1887475Upregulation of PM2.5 induced mRNA expression in human A549 cells at 20 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID658959Antiproliferative activity against estrogen-deficient human MCF7 cells at 1 uM after 72 hrs by MTT assay relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID334635Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID1502707Antimycobacterial activity against Mycobacterium avium 104 mc'2 3 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1083071Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID596671Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1744554Octanol-water distribution coefficient, log D of the compound at pH 7.4 after 1 hr by UV-VIS spectroscopic analysis2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1083047Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID658960Antiproliferative activity against estrogen-deficient human MCF7 cells at 10 uM after 72 hrs by MTT assay relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1719055Antiinflammatory activity in mouse BV2 cells assessed as reduction in LPS-induced NO-production at 20 uM after 24 hrs by Griess reagent based assay relative to control2021Bioorganic & medicinal chemistry letters, 02-15, Volume: 34Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential anti-inflammatory drugs.
AID1083044Drug metabolism in Silene noctiflora shoot assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID429116Ratio of compound IC50 to flutamide IC50 for androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID347258Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation at 200 uM relative to isatin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1860355Selectivity index, log ratio of Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation in presence of arachidonic acid to Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation in pres
AID404069In vivo antitumor activity against mouse L1210 cells
AID1083073Drug metabolism in Geranium molle shoot assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1872429Inhibition of recombinant KDM1A (unknown origin) using H3K4Me2 peptide as substrate incubated for 0.5 hrs by Amplex red assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
AID1083084Drug metabolism in Silene noctiflora shoot assessed as transformation to p-coumaric acid at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1744553Permeability constant, logPe of compound incubated for 2 to 30 hrs by PAMPA assay2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID257080Inhibitory activity against PIM1 at 10 uM2005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID658961Estrogenic activity at estrogen receptor in human Ishikawa cells assessed as induction of alkaline phosphatase expression after 72 hrs by microplate reader2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1083039Drug metabolism in Silene noctiflora root assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083058Drug uptake in Echinochloa crus-galli (barnyard grass) root at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1247840Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay2015Journal of medicinal chemistry, Sep-24, Volume: 58, Issue:18
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
AID347257Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADPH2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1887489Inhibition of PM2.5 induced PI3K upregulation in human A549 cells at 20 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083075Drug metabolism in Silene noctiflora shoot assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887445Cytotoxicity against human A549 cells assessed as reduction in cell viability at 1.5625 to 25 uM incubated for 48 hrs by CCK-8 assay2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID429118Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1083090Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to pratensein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083083Drug metabolism in Geranium molle shoot assessed as transformation to p-coumaric acid at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID429115Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1254158Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID1083049Drug metabolism in Geranium molle root assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887479Downregulation of PM2.5 induced vimentin mRNA expression in human A549 cells at 10 uM by qRT-PCR analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887486Downregulation of PM2.5 induced vimentin expression in human A549 cells at 10 to 30 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID406995Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1083081Drug metabolism in Geranium molle root assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1083091Drug metabolism in Geranium molle shoot assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1854423Inhibition of recombinant LSD1 (unknown origin) incubated for 1 hr2022European journal of medicinal chemistry, Oct-05, Volume: 240A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors.
AID469799Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1083082Drug metabolism in Silene noctiflora root assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887470Downregulation of PM2.5 induced CXCL12 expression in human A549 cells at 20 uM by ELISA relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID1845957Antiproliferative activity against human MGC-803 cells assessed as reduction in cell viability after 72 hrs by MTT assay2021European journal of medicinal chemistry, Mar-15, Volume: 214Annual review of LSD1/KDM1A inhibitors in 2020.
AID84190Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID681206TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 100 uM, Biochanin A: 50 uM) in BCRP-expressing MCF-7 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID30974Evaluated for time required to reach maximum concentration in plasma2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID332397Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumors in potato by disk test relative to control1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1083048Drug metabolism in Geranium molle root assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID265762Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1887465Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration rate at 30 uM incubated for 24 hr by wound healing assay (Rvb = 129%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1651897Inhibition of recombinant human PTP1B (1 to 321 residues) expressed in Escherichia coli at 10 uM using p-nitrophenyl phosphate as substrate incubated for 30 mins relative to control
AID1083103Drug metabolism in Geranium molle shoot assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID658962Estrogenic activity at estrogen receptor in human Ishikawa cells assessed as induction of alkaline phosphatase expression at 1 uM after 72 hrs by microplate reader relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID241414Inhibitory concentration against human placental aromatase2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
AID1651899Cytotoxicity against human insulin resistant HepG2 cells assessed as cell viability at 10 uM by CCK8 assay relative to control
AID479369Inhibition of human placental microsome CYP192010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1083080Drug metabolism in Silene noctiflora root assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887492Inhibition of PM2.5 induced Akt phosphorylation upregulation in human A549 cells at 20 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID398343Inhibition of protein kinase C1995Journal of natural products, Apr, Volume: 58, Issue:4
Dihydrolicoisoflavone, a new isoflavanone from Swartzia polyphylla.
AID238451Apparent Ki against human aromatase2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
AID1254156Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID1083034Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887448Protection against PM2.5 induced human A549 cells injury assessed as reduction in PM2.5 induced cell proliferation inhibition at 10 to 30 uM measured at 72 hrs by CCK-8 analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID680681TP_TRANSPORTER: increase in digoxin intracellular accumulation (VBL: 27nM, biochanin A: 150 uM) in Caco-2 cells2003Pharmaceutical research, Aug, Volume: 20, Issue:8
Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
AID1887488Downregulation of PM2.5 induced MMP-9 activation in human A549 cells at 10 uM by ELISA2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID658953Displacement of fluorescent estrogen ES2 from recombinant ERalpha receptor by fluorescence polarization assay relative to estradiol2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1887484Downregulation of PM2.5 induced fibronectin mRNA level in human A549 cells at 30 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID11154Evaluated for Pharmacokinetic property: Area under the curve2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1887473Inhibition of PM2.5 induced TGF-beta1 secretion in human A549 cells at 30 uM by ELISA relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID469800Estrogenic activity in human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1502716Inhibition of multidrug resistance efflux pump in Mycobacterium avium 104 assessed as increase in EtBr accumulation by measuring relative final fluorescence at 1/2 times MIC incubated for 60 mins by real-time fluorometry relative to control2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID404183Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1083061Drug uptake in Geranium molle root at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1872432Inhibition of MAO-B (unknown origin) at 10 uM relative to control2022European journal of medicinal chemistry, Mar-05, Volume: 231Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
AID1083057Drug uptake in Silene noctiflora shoot at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID332398Cytotoxicity against human A549 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1083105Drug metabolism in Silene noctiflora shoot assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083088Drug metabolism in Geranium molle root assessed as transformation to p-coumaric acid at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083087Drug metabolism in Geranium molle root assessed as transformation to p-coumaric acid at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID347256Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID654681Inhibition of aromatase2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
AID1083063Drug recovery in leaf of Lolium perenne (perennial ryegrass) at 50 ng/g by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083104Drug metabolism in Silene noctiflora shoot assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID84344Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 0.9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID658976Growth stimulation of human Ishikawa cells at at 10 uM after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID681317TP_TRANSPORTER: increase in Vinblastine intracellular accumulation (Vinblastine: 0.05 uM, BiochaninA: 101 uM) in Panc-1 cells2003Journal of pharmaceutical sciences, Feb, Volume: 92, Issue:2
Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.
AID1887449Protection against PM2.5 induced human A549 cells morphological change at 10 to 30 uM measured after 24 hrs by microscopic analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID358171Inhibition of EGFR in human A431 cells1992Journal of natural products, Nov, Volume: 55, Issue:11
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
AID1083100Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID87108Suppression of Hamster ethanol intake by 0.07 mmol o.d. i.p.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1887459Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 30 uM incubated for 24 hr by wound healing assay (Rvb = 1.757 +/- 0.094 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID658956Estrogenic activity at estrogen receptor in human MCF7:D5L cells co-expressing ERE assessed as induction of luciferase gene expression at 1 micoM after 16 hrs by microplate reader relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID643055Induction of rat calvarial osteoblast mineralization assessed as increase in formation of mineralized calcium nodules at 10 nM after 21 days by alizarin red-S staining-based assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1083078Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID358879Antifungal activity against MDR knockout Candida albicans DSY1024 after 24 hrs by XTT assay2001Journal of natural products, Mar, Volume: 64, Issue:3
Three new phenolic compounds from a manipulated plant cell culture, Mirabilis jalapa.
AID1083086Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to p-coumaric acid at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083095Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1386834Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of progesterone-induced PRE activity at 50 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1250230Inhibition of aromatase (unknown origin)2015European journal of medicinal chemistry, Sep-18, Volume: 102Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
AID1599431Inhibition of human placental microsome aromatase using [1beta,2beta3H]androstenedione as substrate after 15 mins in presence of NADPH by liquid scintillation counting method2019European journal of medicinal chemistry, Sep-01, Volume: 177Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID681379TP_TRANSPORTER: inhibition of EGCG in MRP1-expressing MDCKII cells2003Biochemical and biophysical research communications, Oct-10, Volume: 310, Issue:1
Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites.
AID1887454Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 10 uM incubated for 0 hr by wound healing assay (Rvb = 2.120 +/- 0.132 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1502710Antimycobacterial activity against Mycobacterium avium isolate MAV1 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1887463Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration rate at 10 uM incubated for 24 hr by wound healing assay (Rvb = 129%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083043Drug metabolism in Geranium molle shoot assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083077Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID347259Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation using isatin as substrate2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID358880Antifungal activity against wild type Candida albicans SC5314 after 24 hrs by XTT assay2001Journal of natural products, Mar, Volume: 64, Issue:3
Three new phenolic compounds from a manipulated plant cell culture, Mirabilis jalapa.
AID1386836Antagonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as inhibition of progesterone-induced PRE activity at >= 25 uM after 24 hrs by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1887446Cytotoxicity against human A549 cells assessed as reduction in cell viability at 200 uM incubated for 48 hrs by CCK-8 assay relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1502722Inhibition of multidrug resistance efflux pump in Mycobacterium avium 104 mc'2 4 assessed as increase in EtBr accumulation by measuring relative final fluorescence at 1/2 times MIC incubated for 60 mins by real-time fluorometry relative to control2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1719053Cytotoxicity against mouse BV2 cells assessed as reduction in cell viability at 20 uM after 24 hrs by XTT assay2021Bioorganic & medicinal chemistry letters, 02-15, Volume: 34Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential anti-inflammatory drugs.
AID1083079Drug metabolism in Geranium molle root assessed as transformation to sissotrin at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID469803Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1887468Inhibition of cell invasion in PM2.5 induced human A549 cells assessed as reduction in cell invasiveness at 30 uM measured after 24 hrs by Giemsa staining based transwell assay relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887474Upregulation of PM2.5 induced E-cadherin mRNA expression in human A549 cells at 10 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID404182Cytotoxicity against human A549 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID1887455Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 20 uM incubated for 0 hr by wound healing assay (Rvb = 2.120 +/- 0.132 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083042Drug metabolism in Geranium molle shoot assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887457Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 10 uM incubated for 24 hr by wound healing assay (Rvb = 1.757 +/- 0.094 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID313354Cytotoxicity against human PANC1 cells in nutrient deprived medium after 24 hrs2008Bioorganic & medicinal chemistry, Jan-01, Volume: 16, Issue:1
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition.
AID1502709Antimycobacterial activity against Mycobacterium avium ATCC 25291 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID643054Toxicity in rat calvarial osteoblast cells at 1 pM to 1 uM after 48 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1083094Drug metabolism in Silene noctiflora shoot assessed as transformation to pratensein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID336952Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation
AID1083065Drug recovery in leaf of Lolium perenne (perennial ryegrass) at 5 ng/g by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1452998Inhibition of CYP1B1 in human liver microsomes coexpressing recombinant human cytochrome P450 oxidoreductase using 7-ethoxyresorufin as substrate after 3 mins in presence of NADP+ by fluorescence assay2017European journal of medicinal chemistry, Jul-28, Volume: 135Inhibitors of cytochrome P450 (CYP) 1B1.
AID347252Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID456319ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1502715Inhibition of multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 assessed as increase in EtBr accumulation by measuring relative final fluorescence at <= 1/2 times MIC incubated for 60 mins by real-time fluorometry relative to contro2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1860354Inhibition of CYP450 in human liver microsomes assessed as inhibition of EpETrE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
AID1083041Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID404180Cytotoxicity against mouse B16-BL6 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID469801Estrogenic activity in human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol after 96 hrs by alamar blue assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID658963Estrogenic activity at estrogen receptor in human Ishikawa cells assessed as induction of alkaline phosphatase expression at 10 uM after 72 hrs by microplate reader relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1083037Drug metabolism in Geranium molle root assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID335257Chemopreventive activity in Chinese hamster embryonic cells assessed as inhibition of benzo[a]pyrene metabolism at 10 to 25 ug/ml
AID1860353Inhibition of CYP450 in human liver microsomes assessed as inhibition of 20-HETE formation at 10 uM in presence of arachidonic acid and NADPH by multi-enzyme assay based LC-MS/MS analysis relative to control
AID1887460Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration length at 10 uM incubated for 24 hr by wound healing assay (Rvb = 0.363 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID377875Antifungal activity against Giardia intestinalis ATCC 30888 after 48 hrs by XTT assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Antigiardial activity of isoflavones from Dalbergia frutescens bark.
AID1083076Drug metabolism in Silene noctiflora shoot assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083064Drug uptake in Silene noctiflora root at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083036Drug metabolism in Geranium molle root assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID357253Inhibition of Saccharomyces cerevisiae fatty acid synthase2002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID404181Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID347253Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in presence of NADP+2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID1254157Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID1887481Downregulation of PM2.5 induced vimentin mRNA expression in human A549 cells at 30 uM by qRT-PCR analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID293298Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID332400Cytotoxicity against human HT-29 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID378965Antileishmanial activity against Leishmania donovani MHOM/SD/62/IS-CL2D axenic amastigotes after 3 days2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID658957Estrogenic activity at estrogen receptor in human MCF7:D5L cells co-expressing ERE assessed as induction of luciferase gene expression at 10 micoM after 16 hrs by microplate reader relative to untreated vehicle control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1083067Phytotoxicity against Lolium perenne (perennial ryegrass) assessed as root growth inhibition at 100 to 400 uM after 2 weeks by agar medium bioassay2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1719056Antiinflammatory activity in mouse BV2 cells assessed as LPS-induced TNFalpha-production at 20 uM after 24 hrs by Griess reagent based assay relative to control2021Bioorganic & medicinal chemistry letters, 02-15, Volume: 34Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential anti-inflammatory drugs.
AID1083069Phytotoxicity against Geranium molle assessed as root growth inhibition after 2 weeks by agar medium bioassay2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083052Drug uptake in Echinochloa crus-galli (barnyard grass) shoot at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID429119Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID265761Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF542006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1887453Inhibition of cell migration in PM2.5 induced human A549 at 30 uM incubated for 24 hrs by wound healing assay relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID469804Estrogenic activity in luciferase transfected human MCF7 cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1887490Inhibition of PM2.5 induced PI3K upregulation in human A549 cells at 30 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083092Drug metabolism in Geranium molle shoot assessed as transformation to pratensein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID84346Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID658958Antiproliferative activity against estrogen-deficient human MCF7 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1887450Protection against PM2.5 induced human A549 cells morphological change assessed as reduction in number of mesenchymal morphogenetic cells at 10 to 30 uM measured after 48 hrs by microscopic analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID265764Inhibition of FabI at 100 uM2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1887493Inhibition of PM2.5 induced Akt phosphorylation upregulation in human A549 cells at 30 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID596670Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID469806Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 100 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1887478Downregulation of PM2.5 induced N-cadherin mRNA level in human A549 cells at 20 uM by qRT-PCR analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID379092Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379092Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 10 to 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID1083051Drug metabolism in Silene noctiflora root assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID643986Osteogenic activity in rat calvarial osteoblasts assessed as induction of ALP activity at 10 nM after 48 hrs by spectrophotometry in presence of anti-estrogen ICI-1827802012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID242139Inhibitory concentration against human placental aromatase by deutirium oxide release2005Bioorganic & medicinal chemistry, Jun-02, Volume: 13, Issue:12
Synthesis and characterization of azole isoflavone inhibitors of aromatase.
AID1887447Protection against PM2.5 induced human A549 cells injury assessed as reduction in PM2.5 induced cell proliferation inhibition at 10 to 30 uM measured at 24 hrs by CCK-8 analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID243262Inhibitory concentration against human placental aromatase as logIC502004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
AID84188Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 0.3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1386840Agonist activity at PR-b (unknown origin) expressed in Ishikawa cells assessed as increase in PRE activity at 1 uM after 24 hrs in absence of progesterone by luciferase reporter gene based luminescence assay2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1083097Drug metabolism in Geranium molle root assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083085Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to p-coumaric acid at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1719052Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM after 24 hrs by XTT assay relative to control2021Bioorganic & medicinal chemistry letters, 02-15, Volume: 34Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential anti-inflammatory drugs.
AID1254159Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay2015Bioorganic & medicinal chemistry, Nov-15, Volume: 23, Issue:22
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
AID1887451Inhibition of cell invasion in PM2.5 induced human A549 cells assessed as number of cell perforation at 20 uM measured after 24 hrs by Giemsa staining based transwell assay (Rvb = 93 +/- 4.04%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1364654Inhibition of human 17beta-HSD2 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estradiol and NAD+ by scintillation counting method2017Journal of natural products, 04-28, Volume: 80, Issue:4
Potential Antiosteoporotic Natural Product Lead Compounds That Inhibit 17β-Hydroxysteroid Dehydrogenase Type 2.
AID1083102Drug metabolism in Geranium molle shoot assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083050Drug metabolism in Silene noctiflora root assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID125222Inhibition of Hamster Liver mitochondrial Monoamine oxidase.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID84189Inhibition of 5-HIAA formation in isolated Hamster Liver Mitochondria at 0.9 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1887497Inhibition of PM2.5 induced Akt phosphorylation in human A549 cells at 10 to 30 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1386844Induction of PR-b degradation in human Ishikawa cells up to 50 uM after 24 hrs by Western blot analysis2018Journal of natural products, 09-28, Volume: 81, Issue:9
Irilone from Red Clover ( Trifolium pratense) Potentiates Progesterone Signaling.
AID1502712Antimycobacterial activity against Mycobacterium avium isolate MAV3 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1242902Inhibition of porcine pancreatic lipase at 100 ug/ml pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Benzylated and prenylated flavonoids from the root barks of Cudrania tricuspidata with pancreatic lipase inhibitory activity.
AID643972Osteogenic activity in rat primary calvarial osteoblasts assessed as induction of ALP activity at 1 pM to 1 uM after 10 days by colorimetry2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID1887461Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration length at 20 uM incubated for 24 hr by wound healing assay (Rvb = 0.363 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887464Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration rate at 20 uM incubated for 24 hr by wound healing assay (Rvb = 129%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1265116Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID681327TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, BiochaninA: 100 uM) in Panc-1 cells2003Journal of pharmaceutical sciences, Feb, Volume: 92, Issue:2
Effect of flavonoids on MRP1-mediated transport in Panc-1 cells.
AID334634Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction
AID658954Displacement of fluorescent estrogen ES2 from recombinant ERbeta receptor by fluorescence polarization assay relative to estradiol2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID265765Inhibition of FabG at 100 uM2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID293297Antioxidant activity assessed as DPPH radical scavenging activity after 20 min2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1887472Inhibition of PM2.5 induced TGF-beta1 secretion in human A549 cells at 20 uM by ELISA relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887467Inhibition of cell invasion in PM2.5 induced human A549 cells assessed as reduction in cell invasiveness at 20 uM measured after 24 hrs by Giemsa staining based transwell assay relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887485Upregulation of PM2.5 induced E-cadherin expression in human A549 cells at 30 uM by Western blot analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887452Inhibition of cell invasion in PM2.5 induced human A549 cells assessed as number of cell perforation at 10 uM measured after 24 hrs by Giemsa staining based transwell assay (Rvb = 93 +/- 4.04%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID680679TP_TRANSPORTER: increase in digoxin intracellular accumulation (digoxin: 11nM, biochanin A: 150 uM) in Caco-2 cells2003Pharmaceutical research, Aug, Volume: 20, Issue:8
Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
AID1502706Antimycobacterial activity against Mycobacterium avium 104 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID243423Inhibitory concentration against human placental aromatase by deutirium oxide release2005Bioorganic & medicinal chemistry, Jun-02, Volume: 13, Issue:12
Synthesis and characterization of azole isoflavone inhibitors of aromatase.
AID347255Binding affinity to human recombinant carbonyl reductase 3 expressed in Escherichia coli assessed as thermal shift by differential scanning fluorimetry in absence of cofactor2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone.
AID332396Toxicity in brine shrimp larvae1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID84343Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 0.3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1083066Phytotoxicity against Amaranthus caudatus assessed as root growth inhibition at 100 to 400 uM after 2 weeks by agar medium bioassay2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083062Drug uptake in Silene noctiflora root at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID378966Antitrypanosomal activity against Trypanosoma brucei brucei MITat 1.2 variant 221 after 72 hrs2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID1887466Inhibition of cell invasion in PM2.5 induced human A549 cells assessed as number of cell perforation at 30 uM measured after 24 hrs by Giemsa staining based transwell assay (Rvb = 93 +/- 4.04%)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1242901Inhibition of porcine pancreatic lipase pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method2015Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17
Benzylated and prenylated flavonoids from the root barks of Cudrania tricuspidata with pancreatic lipase inhibitory activity.
AID1502711Antimycobacterial activity against Mycobacterium avium isolate MAV2 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1502708Antimycobacterial activity against Mycobacterium avium 104 mc'2 4 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1887469Downregulation of PM2.5 induced CXCL12 expression in human A549 cells at 10 uM by ELISA relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083053Drug uptake in Echinochloa crus-galli (barnyard grass) shoot at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1502713Antimycobacterial activity against Mycobacterium avium isolate MAV4 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1083060Drug uptake in Geranium molle root at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID456186Inhibition of reduced carboxymethylated kappa-casein fibril formation at 5 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1887503Inhibition of PM2.5 induced PI3K/Akt activation assessed as inhibition of Snail expression in human A549 cells at 10 to 20 uM2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID658955Estrogenic activity at estrogen receptor in human MCF7:D5L cells co-expressing ERE assessed as induction of luciferase gene expression after 16 hrs by microplate reader2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
AID1083055Drug uptake in Silene noctiflora shoot at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887477Downregulation of PM2.5 induced N-cadherin mRNA level in human A549 cells at 10 uM by qRT-PCR analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID404179Cytotoxicity against mouse colon 26-L5 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID596673Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1887495Inhibition of PM2.5 induced PI3K expression in human A549 cells at 10 to 30 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID357254Antifungal activity against Candida albicans ATCC 900282002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID1083054Drug uptake in Geranium molle shoot at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID293299Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production2007Bioorganic & medicinal chemistry, Feb-15, Volume: 15, Issue:4
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
AID1887476Reversal of PM2.5 induced EMT in human A549 cells at 10 uM by ELISA2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID357255Antifungal activity against Cryptococcus neoformans ATCC 901132002Journal of natural products, Dec, Volume: 65, Issue:12
Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies.
AID1744547Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL complex formation at 10 uM incubated for 15 mins in presence of cardiolipin by Trp-59 fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1083046Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083099Drug metabolism in Silene noctiflora root assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID596672Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control2011Bioorganic & medicinal chemistry, May-01, Volume: 19, Issue:9
Structural requirements of flavonoids for the adipogenesis of 3T3-L1 cells.
AID1083056Drug uptake in Geranium molle shoot at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887505Inhibition of PM2.5 induced PI3K/Akt activation assessed as inhibition of Twist expression in human A549 cells at 10 to 20 uM2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083096Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to pratensein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1083072Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1872431Inhibition of MAO-A (unknown origin) at 10 uM relative to control2022European journal of medicinal chemistry, Mar-05, Volume: 231Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).
AID1502719Inhibition of multidrug resistance efflux pump in Mycobacterium avium 104 mc'2 3 assessed as increase in EtBr accumulation by measuring relative final fluorescence at 1/2 times MIC incubated for 60 mins by real-time fluorometry relative to control2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1887504Inhibition of PM2.5 induced PI3K/Akt activation assessed as inhibition of Slug expression in human A549 cells at 10 to 20 uM2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID404184Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry, May-15, Volume: 16, Issue:10
Cytotoxic constituents from Brazilian red propolis and their structure-activity relationship.
AID681192TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 20 uM, Biochanin A: 50 uM) in BCRP-expressing NCI-H460 cells2004Molecular pharmacology, May, Volume: 65, Issue:5
Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
AID406996Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 40 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID1083040Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to dihydrobiochanin A at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887471Inhibition of PM2.5 induced TGF-beta1 secretion in human A549 cells at 10 uM by ELISA relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083101Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID244080Inhibitory constant against human placental atomatase at pH 7.0 and 37 degree C2005Bioorganic & medicinal chemistry, Jun-02, Volume: 13, Issue:12
Synthesis and characterization of azole isoflavone inhibitors of aromatase.
AID1502705Antimycobacterial activity against Mycobacterium smegmatis str. MC2 155 assessed as reduction in bacterial viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Nov-10, Volume: 140Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
AID1083068Phytotoxicity against Echinochloa crus-galli (barnyard grass) assessed as root growth inhibition at 100 to 400 uM after 2 weeks by agar medium bioassay2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887491Inhibition of PM2.5 induced Akt phosphorylation upregulation in human A549 cells at 10 uM by Western blot analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1887487Downregulation of PM2.5 induced MMP-2 activation in human A549 cells at 10 uM by ELISA2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083045Drug metabolism in Silene noctiflora shoot assessed as transformation to dihydrobiochanin A at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID643981Estrogenic activity in ER expressing human Ishikawa cells assessed as induction of ALP activity at 10 nM2012Bioorganic & medicinal chemistry letters, Jan-15, Volume: 22, Issue:2
Constituents of Dalbergia sissoo Roxb. leaves with osteogenic activity.
AID429117Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1083098Drug metabolism in Geranium molle root assessed as transformation to pratensein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887483Downregulation of PM2.5 induced fibronectin mRNA level in human A549 cells at 20 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1651898Inhibition of alpha-Glucosidase (unknown origin) at 10 uM using pNPG as substrate incubated for 30 mins relative to control
AID84345Accumulation of 5 HIAL in isolated Hamster Liver Mitochondria at 3 uM.2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID1744549Inhibition of cytochrome c (unknown origin) assessed as reduction reduction of cyt c from its ferric state to ferrous state at 10 uM incubated for 20 mins in presence of cardiolipin by UV-vis Spectrophotometric assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1083074Drug metabolism in Geranium molle shoot assessed as transformation to sissotrin at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1265119Inhibition of recombinant N-terminal His6-tagged AKR1B1 (unknown origin) expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID1744548Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL peroxidase activity at 10 uM up to 20 mins in presence of cardiolipin by Amplex red staining based fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1083093Drug metabolism in Silene noctiflora shoot assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID335258Chemopreventive activity in Chinese hamster embryonic cells assessed as inhibition of benzo[a]pyrene metabolism to water soluble derivatives
AID1845958Cytotoxicity against human GES1 cells assessed as cell viability measured after 72 hrs by MTT assay2021European journal of medicinal chemistry, Mar-15, Volume: 214Annual review of LSD1/KDM1A inhibitors in 2020.
AID406994Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 20 uM2008Journal of medicinal chemistry, Jul-24, Volume: 51, Issue:14
Discovery of nonsteroidal 17beta-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries.
AID265758Inhibition of FabZ2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1083089Drug metabolism in Echinochloa crus-galli (barnyard grass) shoot assessed as transformation to pratensein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887482Downregulation of PM2.5 induced fibronectin mRNA level in human A549 cells at 10 uM by qRT-PCR analysis2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1845956Inhibition of recombinant LSD1 (unknown origin) using H3K4me2 as a substrate measured after 0.5 hrs by fluorescence based analysis2021European journal of medicinal chemistry, Mar-15, Volume: 214Annual review of LSD1/KDM1A inhibitors in 2020.
AID679740TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, BiochaninA: 50 uM) in MDA435/LLC6MDR1 cell2003The Journal of pharmacology and experimental therapeutics, Mar, Volume: 304, Issue:3
Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
AID1651896Inhibition of alpha-Glucosidase (unknown origin) using pNPG as substrate incubated for 30 mins
AID31429Compound was evaluated for the inhibition of Hamster Liver mitochondrial ALDH-2; No inhibition2000Journal of medicinal chemistry, Nov-02, Volume: 43, Issue:22
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.
AID469805Estrogenic activity in luciferase transfected human T47D cells assessed as drug level causing stimulation of cell proliferation equivalent to 10 pM estradiol by luciferase reporter gene assay2009Journal of natural products, Dec, Volume: 72, Issue:12
Flavonoids from the heartwood of the Thai medicinal plant Dalbergia parviflora and their effects on estrogenic-responsive human breast cancer cells.
AID1083059Drug uptake in Echinochloa crus-galli (barnyard grass) root at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID378967Cytotoxicity against african green monkey Vero cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Isoflavonoids and other compounds from Psorothamnus arborescens with antiprotozoal activities.
AID678839TP_TRANSPORTER: cell accumulation of daunomycin in MDA435/LCC6MDR1 cells2003The Journal of pharmacology and experimental therapeutics, Mar, Volume: 304, Issue:3
Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1083038Drug metabolism in Silene noctiflora root assessed as transformation to genistein at 400 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID257079Inhibitory activity against PIM1 at 1 uM2005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.
AID1887456Inhibition of cell migration in PM2.5 induced human A549 assessed as scratch migration length at 30 uM incubated for 0 hr by wound healing assay (Rvb = 2.120 +/- 0.132 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1083035Drug metabolism in Echinochloa crus-galli (barnyard grass) root assessed as transformation to genistein at 20 uM after 14 days measured per gm of dry weight by LC-MS analysis2012Journal of agricultural and food chemistry, Oct-31, Volume: 60, Issue:43
Phytotoxic effect, uptake, and transformation of biochanin A in selected weed species.
AID1887462Inhibition of cell migration in PM2.5 induced human A549 assessed as relative migration length at 30 uM incubated for 24 hr by wound healing assay (Rvb = 0.363 micrometer)2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID332399Cytotoxicity against human MCF7 cells after 7 days1994Journal of natural products, Mar, Volume: 57, Issue:3
Kneglomeratanol, kneglomeratanones A and B, and related bioactive compounds from Knema glomerata.
AID1887480Downregulation of PM2.5 induced vimentin mRNA expression in human A549 cells at 20 uM by qRT-PCR analysis relative to control2022Journal of natural products, 10-28, Volume: 85, Issue:10
Mechanisms of Biochanin A Alleviating PM2.5 Organic Extracts-Induced EMT of A549 Cells through the PI3K/Akt Pathway.
AID1796327CYP19 Assay from Article 10.1021/jm0306024: \\Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.\\2004Journal of medicinal chemistry, Jul-29, Volume: 47, Issue:16
Synthesis and aromatase inhibitory activity of novel pyridine-containing isoflavones.
AID1802929Lipoxygenase Inhibition Assay from Article 10.1080/14756360903179484: \\Conferin, potent antioxidant and anti-inflammatory isoflavone from Caragana conferta Benth.\\2010Journal of enzyme inhibition and medicinal chemistry, Jun, Volume: 25, Issue:3
Conferin, potent antioxidant and anti-inflammatory isoflavone from Caragana conferta Benth.
AID1799665Inhibition Assay from Article 10.1080/14756360109162353: \\Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.\\2001Journal of enzyme inhibition, Jan, Volume: 16, Issue:1
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
AID1796373CYP19 Assay from Article 10.1016/j.bmc.2005.03.050: \\Synthesis and characterization of azole isoflavone inhibitors of aromatase.\\2005Bioorganic & medicinal chemistry, Jun-02, Volume: 13, Issue:12
Synthesis and characterization of azole isoflavone inhibitors of aromatase.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1346840Human Estrogen-related receptor-alpha (3B. Estrogen-related receptors)2003Molecular cancer research : MCR, Nov, Volume: 1, Issue:13
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
AID1346884Human Estrogen-related receptor-beta (3B. Estrogen-related receptors)2003Molecular cancer research : MCR, Nov, Volume: 1, Issue:13
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
AID1346836Human Estrogen-related receptor-gamma (3B. Estrogen-related receptors)2003Molecular cancer research : MCR, Nov, Volume: 1, Issue:13
Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors.
AID1347119qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347124qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347126qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347123qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347122qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347111qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347112qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347116qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347128qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347115qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347118qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347117qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347113qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347125qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347110qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for A673 cells)2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347114qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347127qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347129qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347109qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347121qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Confirmatory screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (409)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (1.71)18.7374
1990's34 (8.31)18.2507
2000's121 (29.58)29.6817
2010's183 (44.74)24.3611
2020's64 (15.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (1.41%)5.53%
Reviews17 (3.98%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.23%)0.25%
Other403 (94.38%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Red Clover Treatment on Bone Tissue Regulation in Postmenopausal Osteopenia. [NCT02174666]85 participants (Actual)Interventional2014-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]